Get started Log in

KNE — Kane Biotech Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Market Cap
CA$6.16m
Enterprise Value
CA$7.26m
Revenue
CA$0.43m

Brief: Kane Biotech Announces Private Placement Offering And Proposed Amendments To Its Credit Facility
03/08/2023 14:52
Brief: Kane Biotech Engages Research Capital To Conduct Strategic Review Of Stem Animal Health
02/08/2023 13:31
Brief: Kane Biotech Announces First Quarter 2023 Financial Results
25/05/2023 22:57
Brief: Kane Biotech Announces Fourth Quarter And Full Year 2022 Financial Results
20/04/2023 21:41
Brief: Kane Biotech Announces Distribution Agreement With Progenacare Global For Its Coactiv+™ Antimicrobial Wound Gel
20/04/2023 12:31
Brief: Kane Biotech Announces Additional Coactiv+™ Animal Health Licensing Agreement
18/04/2023 12:35
Brief: Kane Biotech Announces Extension Of Term Of Credit Facility
06/02/2023 17:10
Brief: Kane Biotech Announces First Distribution Agreement For Its Coactiv+ Antimicrobial Hydrogel
04/01/2023 12:39
Brief: Kane Biotech Announces Loan Transaction
29/12/2022 22:50
Brief: Kane Biotech Announces 510(k) Submission For Its Coactiv+ Antimicrobial Hydrogel
03/11/2022 11:32
Brief: Kane Biotech Announces Second Quarter 2022 Financial Results
25/08/2022 21:19
Brief: Kane Biotech Announces Amended Credit Facility
15/06/2022 13:08
Brief: Kane Biotech Obtains Iso 13485 Certification
18/05/2022 14:35
Brief: Kane Biotech Announces Closing Of Private Placement
17/05/2022 12:17
Brief: Kane Biotech Announces Update On Private Placement
06/05/2022 14:46
Brief: Kane Biotech Announces Extension Of Private Placement Offering
29/04/2022 21:09
Brief: Kane Biotech Announces Fourth Quarter And Full Year 2021 Financial Results
24/03/2022 20:45
Brief: Kane Biotech Successfully Completes Safety And Biocompatibility Studies For Dispersinb Wound Gel
22/03/2022 12:25
Brief: Kane Biotech Announces Private Placement Offering
15/03/2022 11:16
Brief: Kane Biotech Reports Q3 Loss Per Share Of $0.01
16/11/2021 21:16